| Accession Number | 0002029477-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 13, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Class A Common Stock | โ | Apr 9, 2026 | Exercise/Conversion | 3,093 | $27.85 | $86,140.05 | 68,697 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Apr 9, 2026 | Sale | 2,193 | $104.27 | $228,664.11 | 66,504 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Apr 9, 2026 | Sale | 900 | $105.00 | $94,500.00 | 65,604 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Apr 9, 2026 | Exercise/Conversion | 3,093 | $0.00 | $0.00 | 8,309 | Direct | โ | View Details |